Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareCloud (CCLD) Cash & Equivalents (2016 - 2025)

CareCloud (CCLD) has disclosed Cash & Equivalents for 13 consecutive years, with $5.1 million as the latest value for Q3 2025.

  • On a quarterly basis, Cash & Equivalents rose 82.35% to $5.1 million in Q3 2025 year-over-year; TTM through Sep 2025 was $5.1 million, a 82.35% increase, with the full-year FY2024 number at $5.1 million, up 54.46% from a year prior.
  • Cash & Equivalents was $5.1 million for Q3 2025 at CareCloud, down from $10.4 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $21.0 million in Q1 2021 to a low of $2.6 million in Q2 2024.
  • A 5-year average of $7.8 million and a median of $7.7 million in 2023 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: crashed 72.92% in 2023, then soared 298.93% in 2025.
  • CareCloud's Cash & Equivalents stood at $10.3 million in 2021, then grew by 18.95% to $12.3 million in 2022, then plummeted by 72.92% to $3.3 million in 2023, then surged by 54.46% to $5.1 million in 2024, then decreased by 1.4% to $5.1 million in 2025.
  • Per Business Quant, the three most recent readings for CCLD's Cash & Equivalents are $5.1 million (Q3 2025), $10.4 million (Q2 2025), and $6.8 million (Q1 2025).